Table 1.
Patient characteristics
| Parameters | Patients (n=132) | Radiation sensitivity | p-value | |
|---|---|---|---|---|
|
| ||||
| radiation-resistant group | radiation-sensitive group | |||
|
| ||||
| (n=47) | (n=85) | |||
| Age | 0.5591 | |||
| >50 years | 49 | 19 | 30 | |
| ≥50 years | 83 | 28 | 55 | |
| FIGO stage | 0.0041 | |||
| I+II | 70 | 17 | 53 | |
| III+IVa | 62 | 30 | 32 | |
| Histopathological grade | 0.0142 | |||
| High | 10 | 0 | 10 | |
| Middle+Low | 114+8 | 47 | 75 | |
| Tumor diameter | <0.0011 | |||
| ≤4 cm | 79 | 16 | 63 | |
| >4 cm | 53 | 31 | 22 | |
| Combined chemotherapy (platinum-based) | 0.4261 | |||
| Yes | 106 | 36 | 70 | |
| No | 26 | 11 | 15 | |
| Histological type (SCC) | 132 | 47 | 85 | |
| Total dose at point A | ||||
| median dose (range) (Gy) | 92 (67-102) | 89 (66-102) | 0.5853 | |
| EBRT dose of point A | ||||
| median dose (range) (Gy) | 48 (30-52) | 46 (36-50) | 0.5183 | |
| Brachytherapy dose at point A | ||||
| median dose (range) (Gy) | 46 (21-54) | 42 (20-54) | 0.3873 | |
1
p value was estimated by chi-square test.
2
p value was estimated by Fisher’s exact test.
3
p value was estimated by t-test.
FIGO = International Federation of Gynecology and Obstetrics; SCC = Squamous Cell Carcinoma; Gy = gray unit; EBRT = external beam radiation therapy.